Comparative Effectiveness Review: Prostate Cancer Antigen 3 (PCA3) Testing For the Diagnosis and Management of Prostate Cancer

PURPOSE: Compare the effectiveness of PCA3 and select comparators for improving initial or repeat biopsy decision-making in men at risk of prostate cancer, or treatment choices in men with prostate cancer. MATERIALS AND METHODS: MEDLINE®, EMBASE®, Cochrane Database and grey literature were searched from January 1990 through May 2012. Included studies were matched, and measured PCA3 and comparator(s) within a cohort..”